Interferon resistance of emerging SARS-CoV-2 variants

被引:63
|
作者
Guo, Kejun [1 ]
Barrett, Bradley S. [1 ]
Morrison, James H. [1 ]
Mickens, Kaylee L. [1 ,2 ]
Vladar, Eszter K. [3 ]
Hasenkrug, Kim J. [4 ]
Poeschla, Eric M. [1 ,2 ]
Santiago, Mario L. [1 ,2 ]
机构
[1] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA
[4] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; COVID-19; interferons; innate immunity; variants of concern; I INTERFERON; ALPHA; IFN; LANDSCAPE; EMERGENCE; INFECTION; RESPONSES; SUBTYPES; LINEAGE; BETA;
D O I
10.1073/pnas.2203760119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The emergence of SARS-CoV-2 variants with enhanced transmissibility, pathogenesis, and resistance to vaccines presents urgent challenges for curbing the COVID-19 pandemic. While Spike mutations that enhance virus infectivity or neutralizing antibody evasion may drive the emergence of these novel variants, studies documenting a critical role for interferon responses in the early control of SARS-CoV-2 infection, combined with the presence of viral genes that limit these responses, suggest that interferons may also influence SARS-CoV-2 evolution. Here, we compared the potency of 17 different human interferons against multiple viral lineages sampled during the course of the global outbreak, including ancestral and five major variants of concern that include the B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), B.1.617.2 (delta), and B.1.1.529 (omicron) lineages. Our data reveal that relative to ancestral isolates, SARS-CoV-2 variants of concern exhibited increased interferon resistance, suggesting that evasion of innate immunity may be a significant, ongoing driving force for SARS-CoV-2 evolution. These findings have implications for the increased transmissibility and/or lethality of emerging variants and highlight the interferon subtypes that may be most successful in the treatment of early infections.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Emerging SARS-CoV-2 variants of concern and potential intervention approaches
    Jasmin Khateeb
    Yuchong Li
    Haibo Zhang
    Critical Care, 25
  • [32] Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance
    Dholariya, Sagar
    Parchwani, Deepak Narayan
    Singh, Ragini
    Sonagra, Amit
    Motiani, Anita
    Patel, Digishaben
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (04) : 451 - 458
  • [33] Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
    van Breemen, Richard B.
    Muchiri, Ruth N.
    Bates, Timothy A.
    Weinstein, Jules B.
    Leier, Hans C.
    Farley, Scotland
    Tafesse, Fikadu G.
    JOURNAL OF NATURAL PRODUCTS, 2022, 85 (01): : 176 - 184
  • [34] Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
    Dubey, Aakriti
    Choudhary, Shweta
    Kumar, Pravindra
    Tomar, Shailly
    CURRENT MICROBIOLOGY, 2022, 79 (01)
  • [35] How will emerging SARS-CoV-2 variants impact herd immunity?
    Lippi, Giuseppe
    Henry, Brandon M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [36] Emerging SARS-CoV-2 variants of concern and potential intervention approaches
    Khateeb, Jasmin
    Li, Yuchong
    Zhang, Haibo
    CRITICAL CARE, 2021, 25 (01)
  • [37] SARS-CoV-2 variants of concern-An emerging global threat
    Sree, P. Charulata
    Kandi, Venkata Ramana
    Suvvari, Tarun Kumar
    INDIAN JOURNAL OF RESPIRATORY CARE, 2022, 11 (01) : 83 - 84
  • [38] Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control
    Neuzil, Kathleen M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1952 - 1954
  • [39] SARS-CoV-2 emerging variants in Africa: view from Gabon
    Zoa-Assoumou, Samira
    Ndeboko, Benedicte
    Manouana, Gedeon Prince
    Houechenou, Rotimi Myrabelle Avome
    Bikangui, Rodrigue
    Mveang-Nzoghe, Amandine
    Ondo, Georgelin Nguema
    Mbongo-Kama, Elvyre
    Lell, Bertrand
    Abe, Haruka
    Ushijima, Yuri
    Antchouey, Anne-Marie
    Yasuda, Jiro
    Adegnika, Ayola Akim
    Siawaya, Joel Fleury Djoba
    LANCET MICROBE, 2021, 2 (08): : E349 - E349
  • [40] Emerging SARS-CoV-2 Resistance After Antiviral Treatment
    Tamura, Trevor J.
    Choudhary, Manish C.
    Deo, Rinki
    Yousuf, Fizah
    Gomez, Anadela Navarrete
    Edelstein, Gregory E.
    Boucau, Julie
    Glover, Owen T.
    Barry, Mamadou
    Gilbert, Rebecca F.
    Reynolds, Zahra
    Li, Yijia
    Tien, Dessie
    Vyas, Tammy D.
    Passell, Eliza
    Su, Karry
    Drapkin, Sarah
    Abar, Emory G.
    Kawano, Yumeko
    Sparks, Jeffrey A.
    Wallace, Zachary S.
    Vyas, Jatin M.
    Shafer, Robert W.
    Siedner, Mark J.
    Barczak, Amy K.
    Lemieux, Jacob E.
    Li, Jonathan Z.
    JAMA NETWORK OPEN, 2024, 7 (09)